The Hôpital Européen Georges-Pompidou is a French hospital located in Paris. The HEGP is under the aegis of the Assistance publique - Hôpitaux de Paris. Opened in 2001, the HEGP is the last-born Parisian hospital resulting from the merger of three older hospitals of the 15th district.

During the past decade, Service d'Immunologie Clinique - Hôpital européen Georges Pompidou conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Service d'Immunologie Clinique - Hôpital européen Georges Pompidou" #1 collaborator was "Bicetre Hospital" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Pitié-Salpêtrière Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Service d'Immunologie Clinique - Hôpital européen Georges Pompidou" are "HIV Infections" (2 trials) and "HIV Infected Patients With Cancer Treated by ICPi" (1 trials). Many other conditions were trialed in "Service d'Immunologie Clinique - Hôpital européen Georges Pompidou" in a lesser frequency.

Most popular intervention types in "Service d'Immunologie Clinique - Hôpital européen Georges Pompidou" are "Biological" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atazanavir" (1 trials), "Blood sample" (1 trials), "Ritonavir" (1 trials), "Tenofovir" (1 trials) and "Treatment interruption" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service d'Immunologie Clinique - Hôpital européen Georges Pompidou" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Service d'Immunologie Clinique - Hôpital européen Georges Pompidou". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Service d'Immunologie Clinique - Hôpital européen Georges Pompidou, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Service d'Immunologie Clinique - Hôpital européen Georges Pompidou, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".